These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17550235

  • 21. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
    Ayi TC, Tsan JT, Hwang LY, Bowcock AM, Baer R.
    Oncogene; 1998 Oct 22; 17(16):2143-8. PubMed ID: 9798686
    [Abstract] [Full Text] [Related]

  • 22. Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer.
    Kiewhuo K, Priyadarsinee L, Sarma H, Sastry GN.
    J Biomol Struct Dyn; 2023 Oct 22; 41(22):12734-12752. PubMed ID: 36775657
    [Abstract] [Full Text] [Related]

  • 23. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V, Martino-Echarri E, Marzec KA, Mok MT, Brodie KM, Mills K, Lei Y, DeFazio A, Rizos H, Kettle E, Boadle R, Henderson BR.
    Cell Signal; 2015 Sep 22; 27(9):1763-71. PubMed ID: 26022179
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
    Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T.
    Cancer Res; 2005 Jan 01; 65(1):6-10. PubMed ID: 15665273
    [Abstract] [Full Text] [Related]

  • 25. Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50.
    Choudhary RK, Siddiqui MQ, Thapa PS, Gadewal N, Nachimuthu SK, Varma AK.
    Sci Rep; 2017 Jun 20; 7(1):3849. PubMed ID: 28634376
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.
    Tsuzuki M, Wu W, Nishikawa H, Hayami R, Oyake D, Yabuki Y, Fukuda M, Ohta T.
    Cancer Lett; 2006 Feb 20; 233(1):108-16. PubMed ID: 15878232
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.
    Thirumal Kumar D, Udhaya Kumar S, Jain N, Sowmya B, Balsekar K, Siva R, Kamaraj B, Sidenna M, George Priya Doss C, Zayed H.
    Adv Protein Chem Struct Biol; 2022 Feb 20; 130():375-397. PubMed ID: 35534113
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The BRCA1 C-terminal domain: structure and function.
    Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS.
    Mutat Res; 2000 Aug 30; 460(3-4):319-32. PubMed ID: 10946236
    [Abstract] [Full Text] [Related]

  • 32. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M, Schuechner S, Au WW, Henderson BR.
    Exp Cell Res; 2004 Aug 15; 298(2):661-73. PubMed ID: 15265711
    [Abstract] [Full Text] [Related]

  • 33. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T.
    J Biol Chem; 2001 May 04; 276(18):14537-40. PubMed ID: 11278247
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X, Ladias JA.
    Biochemistry; 2013 Oct 29; 52(43):7618-27. PubMed ID: 24073851
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. BARD1 is an ATPase activating protein for OLA1.
    Chen T, Yeh HW, Chen PP, Huang WT, Wu CY, Liao TC, Lin SL, Chen YY, Lin KT, Hsu SD, Cheng HC.
    Biochim Biophys Acta Gen Subj; 2022 May 29; 1866(5):130099. PubMed ID: 35134491
    [Abstract] [Full Text] [Related]

  • 40. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS, Li H, Cevher M, Parmelee A, Fonseca D, Kleiman FE, Lee SB.
    Cancer Res; 2006 May 01; 66(9):4561-5. PubMed ID: 16651405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.